Table 1 Demographic, clinical, and CMR characteristics in all subjects

Age, years

52 (34–65)

48 (30–57)

51 (42–60)

Males, n (%)

22 (41)^‡

11 (42)*

24 (48)

BMI, kg/m²

22.9 ± 5.8

21.5 ± 4.8

22.4 (20.8–25.2)

SBP, mmHg

126 ± 17.3

108 ± 11.8*

122.4 ± 10.3

DBP, mmHg

81.4 ± 11.1

70.5 ± 10.4*

74.3 ± 7.8

Heart rate

83.0 ± 15.5^‡

96.5 ± 17.9*^‡

75.3 ± 9.6

Hct

0.39 ± 0.07^‡

0.35 ± 0.08*^‡

0.43 ± 0.03

cTnT, g/L

12.2 (7.0–45.7)

12.1 (9.8–22.2)

–

NT-proBNP, pg/mL

245 (57–871)

515 (295–1954)

–

AFP

2.2 (1.7–3.0)

2.4 (1.8–3.7)

–

CEA

1.7 (0.7–2.7)

1.4 (0.7–3.2)

–

CA19-9

9.9 (3.7–17.7)

7.4 (5.4–12.8)

–

CA125

21.0 (11.0–45.1)

150 (32.5–457)*

–

Cardiac structure and function

 LVEDVi, mL/m²

75.3 ± 20.2

68.4 ± 25.4

76.6 ± 12.2

 LVESVi, mL/m²

30.5 ± 12.1

28.0 ± 10.8

28.5 ± 7.4

 LVEF, %

59.7 ± 9.2

59.0 ± 7.6

63.4 ± 5.3

 LVmassi, g/m²

63.4 ± 26.1

60.5 ± 30.4

45.5 ± 8.2

 RVEDVi, mL/m²

67.2 ± 18.6

66.7 ± 36.4

70.7 ± 16.5

 RVESVi, mL/m²

35.6 ± 17.7

33.3 ± 21.7

31.7 ± 10.3

 RVEF, %

53.9 ± 11.0

53.6 ± 10.6

57.2 ± 14.2

Characteristics of tumors

 Location

  LA, n (%)

14 (26)

4 (15)

–

  RA, n (%)

16 (30)

12 (46)

–

  LV, n (%)

11 (20)

2 (8)

–

  RV, n (%)

11 (20)

7 (27)

–

  Valves, n (%)

2 (4)

1 (4)

–

 Mobility, n (%)

37 (69)

4 (15)*

–

 Invasiveness, n (%)

3 (6)

20 (77)*

–

 Irregular border, n (%)

10 (19)

16 (62)*

–

 Longest diameter, cm

3.3 (1.9–4.6)

6.5 (4.4–7.4)*

–

 Shortest diameter, cm

2.0 (1.3–3.0)

3.2 (2.4–4.9)*

–

 Pericardial effusion, n (%)

6 (11)

13 (54)*

–

 Tissue characteristics

  T1-weighted, n (%)

   Hypointense

3 (6)

2 (3)

–

   Isointense

48 (89)

21 (81)

–

   Hyperintense

3 (6)

3 (12)

–

  T2-weighted, n (%)

   Hypointense

3 (6)

2 (3)

–

   Isointense

13 (24)

9 (35)

–

   Hyperintense

38 (70)

15 (58)

–

  First-pass perfusion, n (%)

   None

2 (4)

0 (0)

–

   Hypoperfusion

32 (59)

13 (50)

–

   Isoperfusion

8(15)

7 (27)

–

   Hyperperfusion

12 (22)

6 (23)

–

  LGE

   None

14 (26)

3 (12)

–

   Homogeneous

13 (24)

3 (12)

–

   Heterogeneous

27 (50)

20 (77)

–

  Mapping parameters

   T1 mapping (pre)-mass, ms^a

1684 ± 450

1627 ± 410

–

   T1 mapping (post)-mass, ms^a

433 ± 123

412 ± 135

–

   T2 mapping-mass, ms^a

59 ± 25

63 ± 34

–

Tissue characteristics of myocardium

 T1 mapping (pre-contrast)

  T1 mapping-mean, ms

1260 ± 46^‡

1360 ± 61*^‡

1206 ± 44

  T1 mapping-peri, ms

1266 ± 47

1388 ± 96*

–

  T1 mapping-remote, ms

1253 ± 51

1337 ± 67*

–

 T1 mapping (post-contrast)

  T1 mapping-mean, ms

536 ± 63^‡

544 ± 83^‡

503 ± 52

  T1 mapping-peri, ms

546 ± 66

540 ± 82

–

  T1 mapping-remote, ms

544 ± 63

577 ± 75

–

 T2 mapping

  T2 mapping-mean, ms

41 ± 3.0^‡

42 ± 3.2^‡

38 ± 3.1

  T2 mapping-peri, ms

40 ± 3.1

42 ± 3.2

–

  T2 mapping-remote, ms

41 ± 3.0

41 ± 3.7

–

 ECV

  ECV-mean, %

30 ± 2.5^‡

35 ± 5.2*^‡

27 ± 3.0

  ECV-peri, %

29 ± 3.0

36 ± 6.9*

–

  ECV-remote, %

29 ± 2.7

33 ± 5.8*

–

 LGE

  Presence, n (%)

0

3 (12%)

–